Portuguese 
Spanish 
3 min of reading 
0 comments 
Created with US$ 20 thousand, Medvi generated US$ 401 million in 2025 with just two employees and has now become the most explosive case of the new era of lean companies driven by artificial intelligence.
When Sam Altman said in 2024 that artificial intelligence would pave the way for the first billion-dollar company run by a single person, many people dismissed the statement as Silicon Valley exaggeration. Two years later, the market gained a real case too close to this bet to be ignored: Medvi, an American telemedicine startup focused on GLP-1 medications for weight loss, operates with just two employees and is already on track for nearly US$ 2 billion in annual sales.
The story begins in an almost improbable way. Matthew Gallagher, a 41-year-old entrepreneur from Los Angeles, launched Medvi in September 2024 with only US$ 20 thousand, two months of work, and a stack of AI tools.
In 2025, in the company’s first full calendar year, the startup recorded US$ 401 million in revenue, 250 thousand customers, and a net profit of US$ 65 million, with a margin of 16.2%. For 2026, the company is projected to reach US$ 1.8 billion in annual sales.
-
Desert sand, previously discarded by construction, becomes an ecological brick in the United Arab Emirates, using slag and industrial ash, reducing dependence on Portland cement and making a bold bet to cut carbon without kilns or thermal curing in an experimental scale.
-
The south could register more than 250 mm of rain above average in the second half of the year with the arrival of Super El Niño, warns meteorologist.
-
The “blusinhas tax” was canceled in May 2026, and now the government has already confirmed that it will charge tax again on international purchases starting in 2027, this time with no value limit.
-
Not even the end of the ‘roller coaster’ described by the price of Brent crude oil (the main global benchmark) – which jumped from a price of $72 to $120, then dropped to $76 per barrel – due to the recent peace agreement between the US and Iran, was enough to relieve the Brazilian economy from inflationary pressures.
The detail that changes the whole reading
Medvi is not a “solo company” in the literal sense. It has two employees: Gallagher and his brother Elliot.
Still, the case stirs the market’s imagination because it dismantles an old logic of scale.
Instead of a traditional structure with full departments, the startup uses AI to accelerate software, marketing, content, and customer service, compressing operations to a size that seemed impossible for a health business with such aggressive growth.
The comparison with giants in the same sector helps to understand the shock. Hims & Hers, one of the largest references in digital health in the US, closed 2025 with about US$ 2.35 billion in revenue, US$ 128 million in net profit, and 2,442 employees.
This puts its net margin at around 5.4%, well below the 16.2% reported by Medvi in 2025.
Almost US$ 2 billion, but with a huge asterisk
The number that went viral is not the revenue already achieved by the company, but rather the projection for 2026. The actual figure closed so far, according to data reviewed by the American press, was US$ 401 million in 2025.
This difference matters because it helps to separate an already impressive operation from a narrative still surrounded by expectation.
It also weighs that Medvi became the target of scrutiny shortly after exploding. In February 2026, the FDA sent a warning letter to the company regarding promotional content linked to compounded medications with semaglutide and tirzepatide.
Days later, Business Insider revealed that ads linked to Medvi used personas of doctors that apparently did not exist, with manipulated or AI-generated images in affiliate campaigns.
This point transforms the startup into something bigger than just a simple case of efficiency. Medvi shows how far artificial intelligence can push productivity, margin, and speed.
At the same time, it exposes the risk of overly automated growth in a sensitive sector like healthcare, where marketing, trust, and regulation go hand in hand.
The question that remained for the whole market
The hardest part for the rest of the companies is not copying Medvi entirely. It is responding to what it symbolizes.
If an operation with two men, AI, and a minimal structure can enter a path of $1.8 billion in sales, the discussion shifts from how many people a company needs to hire to grow.
The question now is different: how much of the operation still exists because it really needs people — and how much remains just because no one automated it before.
Comment if you believe that AI will indeed create billion-dollar companies with tiny teams and share this article with those who follow technology, startups, and the new artificial intelligence market.
Be the first to react!